Matthew Budoff MD
@BudoffMd
Followers
7K
Following
171
Media
18
Statuses
461
Dr Budoff is a preventive cardiologist and Professor of Medicine at the David Geffen School of Medicine (UCLA) and principal investigator at Lundquist Institute
Torrance CA
Joined June 2020
Proud to serve on the faculty for @ACCinTouch #FusterCVS. Will be discussing appropriate use of calcium scoring and cardiac CT in contemporary medicine #FusterCVS
#CardioTwitter
#ACCEd
0
0
13
Looking forward to speaking at SWFLCIS 2025 this November in St. Pete Beach. Premier cardiac imaging faculty, hands-on CT & MRI workshops, CME, and more. 🗓️ Nov 14–16 at The Don CeSar 👉
0
0
9
An important paper related to our work measuring liver fat on calcium scans showing semaglutide lowers liver fat in our prospective randomized trial - "STOP Trial" https://t.co/PyKPpc8cRu
@novonordisk @bdi_ai
8
2
48
An excellent expert consensus document on statins in geriatrics. Also advocates for CAC scanning to help decision making (IIa recommendation). i am a strong advocate of treating older active adults with statins https://t.co/bWY1JBD5Q5
agsjournals.onlinelibrary.wiley.com
The risk of atherosclerotic cardiovascular disease increases with advancing age. Elevated LDL-cholesterol and non-HDL-cholesterol levels remain predictive of incident atherosclerotic cardiovascular...
11
14
129
NEW JERSEY: Get to know MIKIE SHERRILL: —Voted to RAISE taxes by $3,700 —Voted to give ILLEGALS taxpayer-funded healthcare —Voted to CUT the child tax credit And Sherrill has NO idea what to do as Governor. 🤯 Vote AGAINST her on Nov. 4th.
39
86
243
Further, it is absolutely incorrect to directly compare to our natural history abstract (unpublished), without matching, correcting for baseline plaque and methodologic differences. We will ultimately compare the cohorts. Very disappointed in your reporting of our discussion.
11
3
79
Extremely short video. Where's the rapture for the people in Jamaica, Nigeria, China, Syria? End time Prophecy for the Great Tribulation. A very shocking bible verse that you will never hear in church about The Antichrist and end time Christians.
1
2
3
An excellent paper from my fellow Angelo De La Rosa who published great work on predicting CHF with CAC scans from MESA - https://t.co/Er5Lmtp7t5 continuing work we have been doing for > 20 years.
0
4
40
This Position Statement from Principle Investigator @BudoffMd ended up as dispersed tweets. I've compiled them for clarity 👇 There has been a tremendous amount of interest in our new paper: https://t.co/dhMPUfHjl7 While we appreciate the interest, there have been some
21
45
227
This is the first of a set of papers, with more published data coming soon. I would ask fellow professionals to keep social media dialogue civil and suggest especially that those parties without experience conducting research keep their juvenile attacks to themselves.
There are lots of Problems with the latest Keto- CTA study. But the reason many of us are calling it out is because of the huge promotion campaign going behind what can be best described as dishonest work. & The message that's going out to the laymen is "LDL doesn't matter on
14
5
98
Dr Alo, as you have published ZERO papers in your lifetime, and have no credibility in the field, calling my work dishonest is not acceptable. The change in NCPV was less than the change in PAV%, as shown in figure 1 in the paper, so if anything we put our worst foot forward.
There are lots of Problems with the latest Keto- CTA study. But the reason many of us are calling it out is because of the huge promotion campaign going behind what can be best described as dishonest work. & The message that's going out to the laymen is "LDL doesn't matter on
22
19
222
Finally, these patients were on no other treatments, anti-hypertensives, statins, or other therapies to slow plaque, so a true natural history study, different from many other drug therapy studies. @AdrianSotoMota @nicknorwitz @bschermd@realDaveFeldman @khurramn1 @JACCJournals
4
7
76
This is the first of a set of papers, with more published data coming soon. I would ask fellow professionals to keep social media dialogue civil and especially that those parties without experience conducting research keep their juvenile attacks to themselves.
9
2
99
Importantly —in the population at large (including those with and without CAC at baseline), neither LDL nor ApoB predicted plaque progression, whereas baseline plaque predicted plaque progression. This is novel, a contribution to the literature, and warrants further investigation
11
11
104
However, this does not mean that this population is immune to atherosclerosis — obviously. Like any population, the KETO-CTA participants exhibited a heterogeneous risk profile, and a minority exhibited more rapid progression, as expected.
10
6
50
These lean, metabolically healthy individuals on a #ketodiet exhibited less coronary plaque and lower rates of plaque progression than I would have expected, with the majority exhibiting minimal progression and several exhibiting regression. This is interesting.
22
23
210
When I was offered a volunteer teaching position for children in Romania, I left my job and relocated there. The challenge was significant: no salary, no car, no home. Yet, the inspiration of teaching children was fulfillment enough. Upon arriving in Cluj-Napoca, Romania, in
2
0
20
There has been a tremendous amount of interest in our new paper: https://t.co/f3vcvEBBmv 1/5) While we appreciate the interest, there have been some comments that are unbecoming of fellow clinicians and academics. Let me clarify key points in this thread 🧵👇 **
jacc.org
8
7
78
a nice short paper on when is too young for a CAC scan? https://t.co/iMxDhko8pN
academic.oup.com
This editorial refers to ‘Coronary artery calcification distribution and progression in over 70 000 asymptomatic individuals: implications for assessment i
6
19
75
Completed another prospective serial CCTA trial, this one with Repatha from the great Cedars Sinai team under Dan Berman MD-
1
8
45
These are certainly interesting and important data. We look forward to studying further the unique risk profile of Lean Mass Hyper-Responders. They have a lot to teach us.
🚨FINALLY! The Lean Mass Hyper-Responder 1 Year Data Just Dropped!🚨 https://t.co/dhMPUfHjl7 🫀Most participants showed NO OR MINIMAL or progression of coronary plaque 🫀Neither ApoB nor LDL exposure predicted plaque progression 🫀But plaque predicted plaque progression,
7
5
46